Published in J Am Coll Cardiol on December 01, 1999
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet (2001) 3.38
Calcium and arrhythmogenesis. Physiol Rev (2007) 2.76
Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ Res (2011) 2.37
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol (2007) 2.28
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart (2003) 1.69
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol (2015) 1.56
Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models. PLoS One (2015) 1.53
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation (2005) 1.50
Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts. Acta Physiol (Oxf) (2015) 1.41
Heterogeneity and cardiac arrhythmias: an overview. Heart Rhythm (2007) 1.41
The spectrum of epidemiology underlying sudden cardiac death. Circ Res (2015) 1.26
Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am J Med Genet A (2010) 1.15
Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. J Clin Invest (2005) 1.13
The ryanodine receptor in cardiac physiology and disease. Adv Pharmacol (2010) 1.09
Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol Ther (2009) 1.08
Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med (2006) 1.08
Calsequestrin 2 and arrhythmias. Am J Physiol Heart Circ Physiol (2011) 1.08
Catecholaminergic polymorphic ventricular tachycardia. Eur J Pediatr (2010) 1.08
Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases. J Mol Cell Cardiol (2013) 1.08
Modulation of transmural repolarization. Ann N Y Acad Sci (2005) 1.07
Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia. BMC Med Genet (2009) 1.06
Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice. Heart Rhythm (2010) 1.03
Genomics and genetics in the biology of adaptation to exercise. Compr Physiol (2011) 1.02
Cardiac repolarization. The long and short of it. Europace (2005) 1.00
Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts. Acta Physiol (Oxf) (2008) 0.98
Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn (2006) 0.93
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. Circ Res (2013) 0.91
Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation. Int J Legal Med (2006) 0.88
Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts. Cardiovasc Res (2010) 0.87
Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J Interv Card Electrophysiol (2003) 0.86
Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population. Ann Med (2013) 0.85
Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia. Pediatr Cardiol (2012) 0.85
Abnormal Ca(2+) homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification. Front Physiol (2013) 0.83
A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia. Heart Vessels (2014) 0.82
Impact of Mendelian inheritance in cardiovascular disease. Ann N Y Acad Sci (2010) 0.80
Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases. Int J Legal Med (2012) 0.79
The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles. Pflugers Arch (2015) 0.75
Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular Tachycardia. J Atr Fibrillation (2016) 0.75
Electrical heart disease: Genetic and molecular basis of cardiac arrhythmias in normal structural hearts. Can J Cardiol (2007) 0.75
Array comparative genomic hybridization identifies a heterozygous deletion of exon 3 of the RYR2 gene. Ups J Med Sci (2015) 0.75
Autosomal recessive catecholamine-induced polymorphic ventricular tachycardia. Exp Clin Cardiol (2002) 0.75
Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine. Drug Alcohol Depend (2013) 0.75
Calcium Signaling and Cardiac Arrhythmias. Circ Res (2017) 0.75
Epidemiology of ventricular tachyarrhythmia : Any changes in the past decades? Herzschrittmacherther Elektrophysiol (2017) 0.75
Murine Electrophysiological Models of Cardiac Arrhythmogenesis. Physiol Rev (2017) 0.75
[Ventricular tachycardia under stress : Characteristic symptom or prognostic relevance?]. Herzschrittmacherther Elektrophysiol (2013) 0.75
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet (2000) 5.65
Microsatellite diversity and the demographic history of modern humans. Proc Natl Acad Sci U S A (1997) 4.96
Direct selection: a method for the isolation of cDNAs encoded by large genomic regions. Proc Natl Acad Sci U S A (1991) 3.66
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med (1995) 3.54
Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol (1994) 3.35
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation (2001) 3.34
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol (1999) 3.09
Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03
A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics (1990) 2.95
Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med (2001) 2.76
Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nat Genet (1996) 2.70
Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation (1995) 2.62
Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res (1998) 2.60
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation (1999) 2.29
Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia (2007) 2.11
Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest (1999) 2.06
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology (2001) 1.98
Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation (2007) 1.98
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest (2000) 1.97
Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res (2000) 1.97
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet (1998) 1.85
Genetic control of serum IgE levels and asthma: linkage and linkage disequilibrium studies in an isolated population. Hum Mol Genet (1997) 1.82
Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation (1999) 1.82
Data mining applied to linkage disequilibrium mapping. Am J Hum Genet (2000) 1.78
Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ (1998) 1.77
The Tabby phenotype is caused by mutation in a mouse homologue of the EDA gene that reveals novel mouse and human exons and encodes a protein (ectodysplasin-A) with collagenous domains. Proc Natl Acad Sci U S A (1997) 1.77
Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J (1999) 1.67
Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol (1998) 1.61
Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol (1999) 1.59
Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger. Genomics (2000) 1.57
Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hum Hypertens (2011) 1.56
Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum Mol Genet (1999) 1.55
APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology (2000) 1.51
Downregulated in adenoma gene encodes a chloride transporter defective in congenital chloride diarrhea. Am J Physiol (1999) 1.47
Fine mapping of the congenital chloride diarrhea gene by linkage disequilibrium. Am J Hum Genet (1995) 1.46
Repolarization abnormalities detected by magnetocardiography in patients with dilated cardiomyopathy and ventricular arrhythmias. J Cardiovasc Electrophysiol (2001) 1.45
Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (1997) 1.45
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol (1996) 1.44
Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol (1999) 1.44
Prevalence and predictors of audible physiological third heart sound in a population sample aged 36 to 37 years. Circulation (1994) 1.43
DYX1C1 functions in neuronal migration in developing neocortex. Neuroscience (2006) 1.42
You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation. Eur J Clin Invest (2003) 1.41
Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer (1997) 1.40
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene (2007) 1.39
A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol (2001) 1.39
Phenylketonuria screening registry as a resource for population genetic studies. J Med Genet (2005) 1.38
Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol (1998) 1.38
A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet (2001) 1.36
Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol (1983) 1.36
A novel mutation of the fibrillin gene causing ectopia lentis. Genomics (1994) 1.36
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
A genome scan for developmental dyslexia confirms linkage to chromosome 2p11 and suggests a new locus on 7q32. J Med Genet (2003) 1.35
Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett (1990) 1.35
Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet (1992) 1.35
A dominant gene for developmental dyslexia on chromosome 3. J Med Genet (2001) 1.33
High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer (2009) 1.33
Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31
Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler Thromb (1991) 1.30
Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett (1988) 1.29
Ectodysplasin is a collagenous trimeric type II membrane protein with a tumor necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells. Hum Mol Genet (1999) 1.29
Clustering of private mutations in the congenital chloride diarrhea/down-regulated in adenoma gene. Hum Mutat (1998) 1.28
A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes (1999) 1.27
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet (2000) 1.27
Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology (1997) 1.23
Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health (1991) 1.23
Gene mapping in isolated populations: new roles for old friends? Hum Hered (2000) 1.23
Yeast artificial chromosome-based genome mapping: some lessons from Xq24-q28. Genomics (1991) 1.21
Statistical modelling of the determinants of historical exposure to bitumen and polycyclic aromatic hydrocarbons among paving workers. Ann Occup Hyg (2000) 1.21
Significance of dermal and respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene. Occup Environ Med (1995) 1.21
A narrow segment of maternal uniparental disomy of chromosome 7q31-qter in Silver-Russell syndrome delimits a candidate gene region. Am J Hum Genet (2000) 1.20
A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A (1994) 1.20
Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women. Calcif Tissue Int (1991) 1.20
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens (2000) 1.19
Global analysis of uniparental disomy using high density genotyping arrays. J Med Genet (2005) 1.18
The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative splicing and encodes ectodysplasin-A with deletion mutations in collagenous repeats. Hum Mol Genet (1998) 1.18
Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens (2001) 1.17
Genetic background of congenital chloride diarrhea in high-incidence populations: Finland, Poland, and Saudi Arabia and Kuwait. Am J Hum Genet (1998) 1.17
Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J Biol Chem (1990) 1.15